Oral Antibiotics: Has Your Business Explored These Highly Effective Group of Medicines?

Focal Points:

• What are the latest types of oral antibiotics?
• Why is it beneficial to use solid oral antibiotics?
• Some beneficial partnerships in the domain

For centuries, antibiotics have been used to treat certain types of bacterial infections such as throat infections, ear infections, urinary tract infections, and more. Moreover, antibiotics are also given to patients undergoing critical surgery to prevent infections. However, regular consumption of antibiotics for viral infections can develop antimicrobial resistance among individuals and can lead to side effects. According to recent studies, it is found that oral antibiotics can be as effective as IV antibiotics and help patients recover faster. In this blog, we will discuss some of the latest antibiotics used for treating several infectious diseases, reshaping the healthcare domain.

Which latest types of oral antibiotics should your business be aware of?

Beta-lactam/ beta-lactamase inhibitors have become a powerful oral antibiotic that can effectively treat upper respiratory tract infections such as sinusitis, pharyngitis, and epiglottitis. They can also be beneficial for treating intra-abdominal infections. These antibiotics possess enhanced anti-microbial activity, which helps in treating infections. While analyzing globally, beta-lactam antibiotics are expected to hold the highest market share globally by generating a revenue of $3,437.07 million during the 2023-2032 period. 

Similarly, cephalosporins have acted as effective antibiotics to treat a wide range of serious infections. There are numerous types of cephalosporins available in the market. For instance, cefazolin and cephalexin are the first-generation cephalosporin antibiotics that can be used to treat infections in bones, respiratory systems, biliary tract, etc. Furthermore, macrolides are another group of antibiotics that can be used to treat community-acquired pneumonia and complicated skin infections. For instance, Ketolides have come out as cutting-edge antibiotics that can overcome macrolide bacteria resistance. Similarly, Fidaxomicin can act as a promising antibiotic to treat diarrhea caused by bacteria.

Why are solid oral antibiotics highly in demand?

Nowadays, many healthcare professionals have started preferring oral antibiotics because of their better bioavailability. Bioavailability is the parameter of determining how effectively medicines respond to specific infections. According to the latest research, solid antibiotics possess higher bioavailability compared to liquid ones. It is found that some individuals, especially younger children, have faced difficulty in absorbing liquid antibiotics as they may stay in the stomach for a longer period getting digested. However, tablet antibiotics have overcome this issue by allowing for slower absorption rates into the bloodstream. This is mainly because the presence of excipients in tablets can help the medication work properly by binding and stabilizing the medicine.

Bringing innovations: Some profitable partnerships

The global oral antibiotics industry is experiencing significant growth due to the rising cases of infectious diseases and bacterial infections among individuals globally. Many leading companies in this domain have made beneficial partnerships to foster the competitive landscape. For instance, in November 2023, Melinta Therapeutics, an American biopharmaceutical firm, announced its partnership with Venatorx Pharmaceuticals to commercialize cefepime-taniborbactam. Cefepime-taniborbactam was developed by Venatorx for treating cUTIs (complicated urinary tract infections). In its last-stage study, the company demonstrated that CERTAIN 1, an effective antibiotic including cefepime-taniborbactam, had shown greater efficacy and superiority in treating hospitalized adults suffering from cUTIs. With this partnership, Venatorx aims to advance R&D and regulatory elements of its infectious disease portfolio.

To conclude, the increasing development of effective oral antibiotics to treat various health conditions will drive the sector to generate extensive growth opportunities. Moreover, the growing elderly population, which is vulnerable to infections, can increase the demand for oral antibiotics in the future.

To get more suggestions and detailed insights into the oral antibiotics industry, feel free to talk to our industry experts today!

Related Post